Wedged Insoles for Management of Knee Osteoarthritis
Knee Osteoarthritis
About this trial
This is an interventional treatment trial for Knee Osteoarthritis focused on measuring Osteoarthritis, Cartilage, Musculoskeletal, Biomechanics, Subtype, Footwear, Orthotics, Joint Loading
Eligibility Criteria
Inclusion Criteria:
- Physician-diagnosed knee osteoarthritis (using American College of Rheumatology clinical and radiographic criteria)
- Kellgren-Lawrence grade 1, 2, 3 or 4
- Primary symptoms and disease location must be attributed to medial tibiofemoral compartment
- KOOS pain of 75 points or lower (where 0 is worst pain and 100 is no pain)
Exclusion Criteria:
- X-ray older than 2 years
- Viscosupplementation within past 6 months
- Cortisone injection in past 3 months
- Narcotic pain medication within past 3 months
- Use of knee unloading brace interventions in past 2 months
- Recent (past 6 months) knee or neuromuscular injury that could bias pain assessments or gait analysis results
- No KAM reduction with either lateral or medial wedge insole
Sites / Locations
- Human Performance Laboratory, University of Calgary
Arms of the Study
Arm 1
Arm 2
No Intervention
Experimental
Waitlist Control
Experimental wedged insole
A waitlist control condition, where the participant receives no insole for 3 months. During this 3 month period, the participant will continue to be monitored for outcome variables.
Either a medially wedged or laterally wedged footwear insole (whichever reduces knee joint mechanical loading more, as determined from subject-specific biomechanical tests), constructed using a 3D printer will be inserted into each participant's shoe. The participant will be asked to utilize this insole as much as possible throughout the day over the course of 3 months.